Key Developments: Nanosphere Inc (NSPH.OQ)

NSPH.OQ on NASDAQ Stock Exchange Global Market

0.84USD
29 Aug 2014
Price Change (% chg)

$0.01 (+1.06%)
Prev Close
$0.83
Open
$0.84
Day's High
$0.85
Day's Low
$0.83
Volume
67,743
Avg. Vol
261,490
52-wk High
$2.97
52-wk Low
$0.83

Search Stocks

Latest Key Developments (Source: Significant Developments)

Nanosphere Inc lowers FY 2014 revenue guidance
Wednesday, 6 Aug 2014 04:01pm EDT 

Nanosphere Inc:Resets FY 2014 guidance to $14 million in revenue, down from the previous guidance of $19 million to $21 million.FY 2014 revenue of $19 million - Thomson Reuters I/B/E/S.  Full Article

Nanosphere Inc's verigene enteric pathogens test receives FDA clearance
Tuesday, 24 Jun 2014 06:00pm EDT 

Nanosphere Inc:Receives U.S. Food and Drug Administration (FDA) 510(k) clearance for the bacterial portion of its Verigene┬« Enteric Pathogens Nucleic Acid Test (EP).Clinical studies for the full panel, including two additional viral targets, have been completed and the Company expects clearance of the full EP panel.  Full Article

Nanosphere signs molecular diagnostic supply agreement with HealthTrust
Monday, 23 Jun 2014 08:00am EDT 

Nanosphere Inc:Says it has been selected by HealthTrust as a provider of multi-target molecular diagnostic tests for the nearly 1,400 acute care facilities that are part of the HealthTrust membership.Says HealthTrust will offer its members access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostic infectious disease tests, including those designed to rapidly and accurately detect infections of the bloodstream, respiratory tract and gastrointestinal tract.Says agreement became effective on June 1.  Full Article

Nanosphere Inc reaffirms FY 2014 revenue guidance
Wednesday, 7 May 2014 08:00am EDT 

Nanosphere Inc:Reaffirms FY 2014 revenue guidance of $19 mln to $21 mln.FY 2014 revenue of $20 mln - Thomson Reuters I/B/E/S.  Full Article

Nanosphere Inc issues FY 2014 revenue guidance in line with analysts' estimates
Wednesday, 12 Feb 2014 08:00am EST 

Nanosphere Inc:Expects to generate $19-$21 mln in revenue in FY 2014.FY 2014 revenue of $19.72 mln - Thomson Reuters I/B/E/S.  Full Article

Nanosphere Inc Reaffirms FY 2013 Revenue Guidance
Wednesday, 6 Nov 2013 08:00am EST 

Nanosphere Inc announced that for fiscal 2013, it re-affirming its revenue guidance of $10 million to $11 million.  Full Article

Nanosphere Inc Prices $26.3 Million Public Offering Of Common Stock
Friday, 13 Sep 2013 09:00am EDT 

Nanosphere, Inc announced that the pricing of its previously announced underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $1.75 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. is acting as the sole book-running manager and Canaccord Genuity Inc. and Cowen and Company, LLC acted as co-managers for the offering. Net proceeds from the sale of the shares after underwriting discounts and commissions and other offering expenses are expected to be approximately $24.1 million. If the underwriters exercise their over-allotment option in full, net proceeds from the offering will be approximately $27.7 million. The offering is subject to customary closing conditions and is expected to close on September 18, 2013.  Full Article

Nanosphere Inc Announces Commencement of Public Offering of Common Stock
Thursday, 12 Sep 2013 04:00pm EDT 

Nanosphere Inc announced that it intends to offer shares of its common stock in a public offering. Nanosphere also expects to grant the underwriters a 30-day option to purchase additional shares of common stock to cover overallotments, if any. Piper Jaffray & Co. is acting as the sole book-running manager for the offering. Nanosphere plans to use the net proceeds from the offering for general corporate purposes and working capital. This offering will be made pursuant to a prospectus supplement to the Company's prospectus, dated November 5, 2012, filed as part of the Company's effective $100 million shelf registration statement.  Full Article

Nanosphere Inc Lowers FY 2013 Revenue Guidance
Tuesday, 6 Aug 2013 04:01pm EDT 

Nanosphere Inc revised fiscal 2013 revenue guidance and expects revenue of $10-$11 million.  Full Article

Nanosphere Inc Seals Distribution and Collaboration Deal with Hitachi High-Technologies Corp Reach Distribution Deal- M2 Pharma
Monday, 13 May 2013 08:00pm EDT 

M2 Pharma reported that Nanosphere Inc announced that it has inked a distribution and collaboration deal with Hitachi High-Technologies Corp to market its products in Japan. Under the deal, Hitachi High-Technologies will gain exclusive rights to commercialise Nanosphere products in Japan, specifically its molecular diagnostics platform Verigene System. The parties will also collaborate on the development of assays and platforms.  Full Article

Search Stocks